Permian Investment Partners
Permian Investment Partners is a hedge fund founded in 2007 by then founder Cara Goldenberg,[2] and joined by co-partners Alex Duran and Scott Hendrickson in 2008 prior to the firm's launch.[1] Its name is derived from the Permian geological period.[3] Its offices are currently located at 295 Madison Avenue, New York NY.[4]
![]() | |
| Type | Limited Partnership[1] |
|---|---|
| Industry | Investment Management |
| Founded | 2008[1] |
| Headquarters | , |
Area served | Worldwide |
| Website | www |
The fund employs a long/short equity strategy with a focus on management change and management quality, predominantly in Western Europe.[5]
The firm was the recipient of the 2012 Europe-Focused Global Emerging Manager award presented by S&P Capital IQ.[6] In November 2011, Permian was among several large shareholders to publicly oppose Sun Pharmaceuticals' offer to acquire Taro Pharmaceuticals.[7]
References
- "Businessweek Company Overview". Archived from the original on August 8, 2013.
- "From analyst to hedge fund founder in six years".
- "HFM Week Online".
- "SEC Form ADV".
- "Emerging Manager Monthly".
- "S&P Capital IQ".
- "PR Newswire".
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

